Dollar Amounts
USD (Millions)
Showing latest financials
Data in millions of USD
Doing some research...
Over the past five years, Walgreens Boots Alliance’s revenue has seen remarkable growth, jumping from $31.4 billion in 2020 to $147.7 billion in 2024. The most notable surge occurred between 2022 and 2023, when revenue increased by over 316%, suggesting significant scale expansion or strategic initiatives. However, this top-line growth has not been accompanied by parallel improvements in profitability. Gross profit increased modestly over the period—from $6.63 billion in 2020 to approximately $26.5 billion in 2024—but the margin appears to have compressed, particularly in 2024, when gross profit slightly declined compared to 2023 despite higher revenue. The operating income trend reflects this challenge. After an operating income of $1.31 billion in 2020 and an improvement to $2.34 billion in 2021, the company saw a sharp decline to $1.39 billion in 2022, followed by a drastic swing into negative territory with losses of $6.88 billion in 2023 and $14.08 billion in 2024—representing year-over-year changes well beyond 20%. A similar trend is observed in net income, which shifted from a small loss in 2020 and a robust gain of $3.58 billion in 2021 to a significant loss of $3.72 billion in 2022, further deepening to losses of $3.08 billion and $8.64 billion in 2023 and 2024, respectively. These data-driven trends suggest that while the company has aggressively expanded its revenue base, escalating operating challenges and margin pressures have raised concerns over its operational efficiency and long-term financial sustainability within the competitive retail pharmacy and healthcare industry.
This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.